IAI FigSearch
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 17 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
IAI.01404-07v1
76/3/1153    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lazarus, J. J.
Right arrow Articles by Wooten, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lazarus, J. J.
Right arrow Articles by Wooten, R. M.

 Previous Article  |  Next Article 

Infect. Immun. doi:10.1128/IAI.01404-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Viable Borrelia burgdorferi Enhance Interleukin-10 Production and Suppress Activation of Murine Macrophages

John J. Lazarus, Maria A. Kay, Akisha L. McCarter, and R. Mark Wooten*

Department of Medical Microbiology and Immunology, University of Toledo Health Science Campus, Toledo, Ohio 43614, USA

* To whom correspondence should be addressed. Email: R.Mark.Wooten{at}utoledo.edu.


   Abstract

Although capable of eliciting strong innate and adaptive immune responses, Borrelia burgdorferi (Bb) often evades immune clearance through largely unknown mechanisms. Our previous studies determined that infected IL-10-/- mice show significantly lower Bb levels than wild type (B6) mice, and that IL-10 inhibits innate immune responses critical for controlling Bb infection. To determine whether virulent Bb preferentially enhances IL-10 production, we developed an in vitro co-culture medium (RPMI.B) in which both Bb and primary macrophages (MØs) remain viable. Bb grew at similar rates and was able to regulate expression of immunoreactive proteins with similar kinetics in RPMI.B as bacteria grown in traditional BSK medium; in contrast, Bb cultured in conventional tissue culture medium (RPMI) rapidly lost viability. Co-culture of viable Bb (RPMI.B) with MØs resulted in a more rapid and significant increase in IL-10 transcripts and secreted protein than co-cultures with non-viable Bb (RPMI), which corresponded with decreased production of proinflammatory cytokines. Addition of live Bb to MØs in RPMI.B also elicited substantially higher IL-10 levels than did heat-killed bacteria, confirming that increased IL-10 production was not inherent to co-culture in RPMI.B. Transfer of supernatants from Bb-stimulated MØs onto naïve MØ cultures resulted in suppressed activation upon subsequent stimulation with different bacterial agonists, and this suppression was obviated by IL-10-specific antibody. In vivo analyses determined that murine skin samples exhibited a substantial upregulation of IL-10 within 24h of Bb injection. Together, these results suggest that viable Bb can suppress early MØ responses during infection by causing increased release of IL-10.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.